https://doi.org/10.1136/gut.2010.224154
I
Ian Arnott
NHS Lothian(GB)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
253
Papers
13.0K
Citations
51
h-index
96
i10-index
Ian Arnott is an academic researcher from NHS Lothian. The author has contributed to research in topics: Inflammatory Bowel Disease & Microscopic Colitis & Eosinophilic Esophagitis. The author has an h-index of 51, co-authored 216 publications.
ORCID: 0000-0003-3352-9253Papers by this author
worksGuidelines for the management of inflammatory bowel disease in adults
2011 · Gut · 1,428 citations
Infliximab versus ciclosporin for steroid-resistant acute severe ulcerative colitis (CONSTRUCT): a mixed methods, open-label, pragmatic randomised trial
2016 · The Lancet. Gastroenterology & hepatology · 253 citations
https://doi.org/10.1016/s2468-1253(16)30003-6
SARS-CoV-2 vaccination for patients with inflammatory bowel disease: a British Society of Gastroenterology Inflammatory Bowel Disease section and IBD Clinical Research Group position statement
2021 · The Lancet. Gastroenterology & hepatology · 137 citations
https://doi.org/10.1016/s2468-1253(21)00024-8
Systemic Inflammation in Preclinical Ulcerative Colitis
2021 · Gastroenterology · 127 citations
https://doi.org/10.1053/j.gastro.2021.07.026
Real-world Effectiveness and Safety of Vedolizumab for the Treatment of Inflammatory Bowel Disease: The Scottish Vedolizumab Cohort
2019 · Journal of Crohn s and Colitis · 50 citations
https://doi.org/10.1093/ecco-jcc/jjz042
Temporal Trends in Surgical Resection Rates and Biologic Prescribing in Crohn’s Disease: A Population-based Cohort Study
2020 · Journal of Crohn s and Colitis · 35 citations
https://doi.org/10.1093/ecco-jcc/jjaa044
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat